Viewing StudyNCT04023721



Ignite Creation Date: 2024-05-06 @ 1:27 PM
Last Modification Date: 2024-10-26 @ 1:14 PM
Study NCT ID: NCT04023721
Status: TERMINATED
Last Update Posted: 2020-07-22
First Post: 2019-06-21

Brief Title: Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor
Sponsor: F-star Therapeutics Inc
Organization: F-star Therapeutics Inc

Organization Data

Organization: F-star Therapeutics Inc
Class: INDUSTRY
Study ID: SBP-9200-HBV-206
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: F-star Therapeutics Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
PRA Health Sciences INDUSTRY